Omada Health president sells 4,036 shares

Q: What insider transaction did OMDA report for President Wei-Li Shao?

President Wei-Li Shao reported selling 4,036 OMDA common shares on September 10, 2026 in open market or private transactions under a Rule 10b5-1 trading plan adopted on March 13, 2026.

Q: At what prices did the OMDA insider sell shares on September 10, 2026?

Wei-Li Shao sold 3,636 shares at a weighted average price of $21.78 (trades between $21.38 and $22.26) and 400 shares at a weighted average price of $22.53 (trades between $22.41 and $22.68).

Q: Was the OMDA insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the sales were made pursuant to a Rule 10b5-1 trading plan adopted by Wei-Li Shao on March 13, 2026, indicating the trades were pre-arranged.

Q: Do the OMDA Form 4 filings show Wei-Li Shao’s remaining holdings?

No. For the reported transactions, the field for shares owned following the transaction is left blank, so this filing does not state Wei-Li Shao’s remaining OMDA share balance.

Omada Health’s president reported selling 4,036 OMDA shares on September 10, 2026 under a pre-arranged Rule 10b5-1 trading plan.

Available on EDGAR 09/14/2026 - 05:11 PM EDT Accepted by SEC EDGAR 09/14/2026 - 05:11 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Omada Health, Inc. (OMDA) reported that President Wei-Li Shao sold a total of 4,036 shares of common stock on September 10, 2026. The sales were made in open market or private transactions at weighted average prices of $21.78 for 3,636 shares and $22.53 for 400 shares, pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026.

Insider Trade Summary 10b5-1

Net Seller: 4,036 shares

Net Sell 2 txns

Insider Shao Wei-Li

Role President

Sold 4,036 shs ($88K)

Share of Position Sold 1.3%

Type	Security	Shares	Price	Value
Sale	Common Stock ^{F1, F2}	3,636	$21.7803	$79K
Sale	Common Stock ^{F1, F3}	400	$22.5325	$9K

Holdings After Transaction: Common Stock — 295,313 shares (Direct)

Holdings Before and After: Common Stock, 299,349 to 295,313 shares (Direct)

Other Insiders: 3 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (3)

F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
F2. This transaction was executed in multiple trades at prices ranging from $21.38 to $22.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3. This transaction was executed in multiple trades at prices ranging from $22.41 to $22.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Total shares sold: 4,036 shares Shares sold (first transaction): 3,636 shares Weighted average price (first transaction): $21.78 per share +3 more

6 metrics

Total shares sold 4,036 shares Aggregate OMDA common shares sold by President Wei-Li Shao on September 10, 2026

Shares sold (first transaction) 3,636 shares Common stock sale on September 10, 2026 at weighted average price

Weighted average price (first transaction) $21.78 per share 3,636-share sale; trades ranged from $21.38 to $22.26

Shares sold (second transaction) 400 shares Common stock sale on September 10, 2026 at weighted average price

Weighted average price (second transaction) $22.53 per share 400-share sale; trades ranged from $22.41 to $22.68

Rule 10b5-1 plan adoption date March 13, 2026 Date Wei-Li Shao adopted the trading plan used for these sales

Key Terms

Rule 10b5-1 trading plan, weighted average price, open market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported above reflects the weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did OMDA report for President Wei-Li Shao?

President Wei-Li Shao reported selling 4,036 OMDA common shares on September 10, 2026 in open market or private transactions under a Rule 10b5-1 trading plan adopted on March 13, 2026.

At what prices did the OMDA insider sell shares on September 10, 2026?

Wei-Li Shao sold 3,636 shares at a weighted average price of $21.78 (trades between $21.38 and $22.26) and 400 shares at a weighted average price of $22.53 (trades between $22.41 and $22.68).

How many OMDA shares in total did President Wei-Li Shao sell?

On September 10, 2026, President Wei-Li Shao sold a total of 4,036 OMDA common shares, combining 3,636 shares in one transaction and 400 shares in another.

Was the OMDA insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the sales were made pursuant to a Rule 10b5-1 trading plan adopted by Wei-Li Shao on March 13, 2026, indicating the trades were pre-arranged.

Do the OMDA Form 4 filings show Wei-Li Shao’s remaining holdings?

No. For the reported transactions, the field for shares owned following the transaction is left blank, so this filing does not state Wei-Li Shao’s remaining OMDA share balance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shao Wei-Li

(Last)

(First)

(Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO

CALIFORNIA

94080

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/10/2026		S⁽¹⁾		3,636	D	$21.7803⁽²⁾	295,713	D
Common Stock	09/10/2026		S⁽¹⁾		400	D	$22.5325⁽³⁾	295,313	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

2. This transaction was executed in multiple trades at prices ranging from $21.38 to $22.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades at prices ranging from $22.41 to $22.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Nathan Salha, as Attorney-in-Fact for Wei-Li Shao	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR